Plug Power Signs Letter of Intent with Hy2gen for 5MW PEM Electrolyzer Supporting France’s Hydrogen Roadmap at Sunrhyse Green Hydrogen Project

(NASDAQ:PLUG), Agreement advances renewable, RFNBO-certified hydrogen production in southern France. Partnership supports logistics and mobility decarbonization across the Provence-Alpes-Cote d'Azur region. Project expands Plug's European footprint through collaboration with Hy2gen on green hydrogen solutions. SLINGERLANDS, N.Y., Dec. 04, 2025 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for […]

HEROES, HEART & HOPE GALA RAISES OVER $2.4 MILLION TO EXPAND ACCESS TO ADAPTIVE SPORTS, GRANTS AND INCLUSIVE PROGRAMS IN THE NORTHEAST

New York, NY, Dec. 04, 2025 (GLOBE NEWSWIRE) — The Challenged Athletes Foundation's (CAF) 19th annual Heroes, Heart & Hope Gala returned to Casa Cipriani South in New York City on Monday, November 17, raising over $2.4 million to support life-changing grants for adaptive sports equipment, coaching, clinics, travel, and inclusive school-based programs that open

MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress

(NASDAQ:MPLT), Topline results from Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected in the second half of 2026 Topline results from Phase 2 VISTA trial of ML-007C-MA for Alzheimer's disease psychosis expected in the second half of 2027 Raised $296.5 million in gross proceeds from initial public offering and concurrent private placement completed in

Nexus closes $700 million fund to back founders building transformative AI, consumer and fintech startups

MENLO PARK, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) — Nexus Venture Partners (“Nexus”), a leading Silicon Valley venture capital firm investing in transformational startups across the United States and India, today announced the closing of Nexus Ventures VIII, a $700 million fund to back exceptional founders building AI, enterprise software, consumer and fintech startups at

SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery

(NASDAQ:FTRE), PRAGUE, Czech Republic and DURHAM, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) — SCTbio, a leading European CDMO specializing in GMP manufacturing for cell-based products, and Fortrea, a leading global contract research organization (CRO), today announced a strategic collaboration agreement between the two companies. This partnership aims to streamline development, accelerate timelines and bring advanced

LKQ Corporation Initiates Sale Process for Specialty Segment

(NASDAQ:LKQ), ANTIOCH, Tenn., Dec. 04, 2025 (GLOBE NEWSWIRE) — LKQ Corporation (Nasdaq: LKQ) today announced that it has commenced a process to explore the potential sale of its Specialty segment. “Our Specialty segment is a leading distributor of automotive, RV and marine parts and accessories in North America. It is a strong business supported by

Winnebago Industries to Announce First Quarter Fiscal 2026 Financial Results on December 19, 2025

(NYSE:WGO), EDEN PRAIRIE, Minn., Dec. 04, 2025 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor recreation product manufacturer, plans to issue its first quarter fiscal 2026 financial results before the opening of the New York Stock Exchange on Friday, December 19, 2025. At 9:00 a.m. CT, the company will conduct a conference

Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement

(NASDAQ:DNLI),(NASDAQ:RPRX), SOUTH SAN FRANCISCO, Calif. and NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI) and Royalty Pharma plc (Nasdaq: RPRX) today announced a $275 million synthetic royalty funding agreement based on future net sales of tividenofusp alfa. Tividenofusp alfa is Denali's lead investigational TransportVehicle(TM)-enabled enzyme replacement therapy for the treatment

REPEAT — QGold Strengthens Board of Directors with Appointment of Jamsheed Mehta, former Vice-Chair at BMO Capital Markets

(TSX-V:QGR),(Pinksheets:QGLDF),(PinkSheets:QGLDF),(Frankfurt:QX9G),(OTC US:QGLDF),(OTCQB:QGLDF), TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Borse Frankfurt: QX9G) (“QGold” or the “Company“) is pleased to announce the appointment of Jamsheed Mehta to its Board of Directors, effective immediately. Mr. Mehta brings over 35 years of capital markets experience, including a distinguished 31-year tenure at

Microbix Announces Initiation of Normal Course Issuer Bid

(TSX:MBX),(OTC US:MBXBF),(Other OTC:MBXBF), MISSISSAUGA, Ontario, Dec. 04, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix(R)) (“Microbix” or the “Company”), a life sciences innovator, manufacturer, and exporter, announces the initiation of a Normal Course Issuer Bid (“NCIB“) program for the repurchase and cancellation of outstanding common shares. Specifically, the NCIB enables Microbix

Scroll to Top